Where does b-ONE Medical Biotech Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), b-ONE Medical Biotech Corporation ranks #34,394 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does b-ONE Medical Biotech Corporation hold?

b-ONE Medical Biotech Corporation holds 7 US utility patents granted between 2020 and 2024, spanning 9 technology areas.

What is b-ONE Medical Biotech Corporation's Innovation Score?

b-ONE Medical Biotech Corporation has an Innovation Score of 29.6 out of 100 (31st percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does b-ONE Medical Biotech Corporation focus on?

b-ONE Medical Biotech Corporation's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 3 patents. Grants appear in 9 CPC subclasses total.

Is b-ONE Medical Biotech Corporation's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for b-ONE Medical Biotech Corporation.

What does claim depth mean for b-ONE Medical Biotech Corporation's patents?

b-ONE Medical Biotech Corporation's patents average 11.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the b-ONE Medical Biotech Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

b-ONE Medical Biotech Corporation

USPTO PatentsView assignee record - 7 granted patents across 9 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, b-one ranks #34,394 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 9 technology areas.

#34,394
of 49,997 US assignees by volume: 31st percentile
by Innovation Score (29.6/100): 11.4
avg claims per patent

USPTO PatentsView assignee plate

Corpus R34394 · Foreign Corporation #34,394 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 7 grants
MID-PACK #34,394/49,997
PHOTO-FINISH adidas International…
CPC-NARROW A61B · 9 areas
INNOV-THIN 29.6/100
CLAIMS-PAR 11.4 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2020–2024 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: adidas International Marketing B.V. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
b-ONE Medical Biotech · this assignee

30
3D Lighting… · lowest

7

What this shows b-one's Innovation Score is 29.6/100 (31st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where b-one's grants concentrate

b-ONE Medical Biotech Corporation is a focused PatentsView assignee: 9 CPC subclasses with 42.9% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (2 grants) versus a trough of 1 in 2023. By volume, b-one sits between ZÜND Systemtechnik AG and eTurboTouch Technology Inc..

b-one's three-year grant acceleration

b-ONE Medical Biotech Corporation shows 3 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

ZÜND Systemtechnik

7
adidas Internatio…

7
ads-tec

7
ancosys

7
bredent & KG

7
ebrands Global Oy

7
enow

7
eturbotouch Techn…

7
b-one Medical Bio… ◀

7

What this shows b-ONE holds 7 patents at rank #38,447, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near b-ONE

By rank, the assignees closest to #38,447 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in b-ONE's primary technology class.

b-one's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 31st percentile higher than 31% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

b-ONE Medical Biotech Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	2	28.6%
2021	2	28.6%
2023	1	14.3%
2024	2	28.6%

Which technologies does b-ONE Medical Biotech Corporation patent most?

A61B - DIAGNOSIS; SURGERY; Identification 3

B25B - Tools OR Bench Devices NOT Otherwise Provided FOR, FOR Fastening, Connecting, Disengaging OR Holding 3

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 3

B33Y - Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective Laser Sintering 2

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 1

C08F - Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

B22F - Working Metallic POWDER; Manufacture OF Articles From Metallic POWDER; Making Metallic Powder ; Apparatus OR Devices Specially Adapted FOR Metallic Powder 1

Top 9 of 9 technology areas

Where it ranks

Overall rank by patents

#34,394

of 49,997 tracked assignees

Innovation Score

29.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

b-ONE Medical Biotech Corporation's patent record in context - here's where to go next.

b-ONE Medical Biotech Corporation's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 42.9% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #34,394 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare b-ONE Medical Biotech Corporation against ZÜND Systemtechnik AG, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.